London, UK--(Marketwire - September 7, 2007) -
SkyePharma PLC
Appointment of Adviser
LONDON, UK, 7 September 2007 - SkyePharma PLC (LSE: SKP) announces the
appointment of Piper Jaffray Ltd. as its joint broker and joint financial
adviser, to work alongside its existing broker and financial adviser,
Credit Suisse Securities (Europe) Limited, with immediate effect.
For further information please contact:
SkyePharma PLC Frank Condella +44 20 7491 1777
Ken Cunningham
Peter Grant
Financial Dynamics (UK Enquiries) David Yates +44 20 7831 3113
Deborah Scott
Trout Group (US Enquiries) Christine Labaree +1 617 583 1308
Seth Lewis
About SkyePharma PLC
Using its proprietary drug delivery technologies, SkyePharma develops new
formulations of known molecules to provide a clinical advantage and life-
cycle extension. The Company has eleven approved products in the areas of
oral, inhalation and topical delivery. The Group's products are marketed
throughout the world by leading pharmaceutical companies.
For more information, visit
www.skyepharma.com
This information is provided by RNS
The company news service from the London Stock Exchange